Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 7, 2004, Pages 534-541

  Odze, Robert D ^a   Farraye, Francis A ^c   Hecht, Jonathan L ^b   Hornick, Jason L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

DALM; dysplasia associated lesion or mass

Indexed keywords

ADENOCARCINOMA; ADENOMA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON RESECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPLASIA; ENDOSCOPIC POLYPECTOMY; EVALUATION; FEMALE; FOLLOW UP; GASTROINTESTINAL POLYPOSIS; HUMAN; HUMAN TISSUE; LONG TERM CARE; MALE; PATIENT MONITORING; PRIMARY SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

ADENOMA; ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POLYPS; COLONOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS;

EID: 3042574699     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00237-X     Document Type: Article

References (25)

1. Goldman H. Significance and detection of dysplasia in chronic colitis. Cancer. 78:1996;2261-2263
2. Riddell R.H., Golman, Ransohoff D.F., et al. Dysplasia in inflammatory bowel disease standardized classification with provisional clinical applications. Hum Pathol. 14:1983;931-968
3. Bansal P., Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol. 91:1996;44-48
4. Connell W.R., Lennard-Jones J.E., Williams C.B., Talbot I.C., Price A.B., Wilkinson K.H. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology. 107:1994;934-944
5. Odze R.D. Adenomas and adenoma-like DALMS in chronic ulcerative colitis a clinical, pathological, and molecular review. Am J Gastroenterol. 94:1999;1746-1750
6. Friedman S., Odze R.D., Farraye F.A. Management of neoplastic polyps in inflammatory bowel disease. Inflamm Bowel Dis. 9:2003;260-266
7. Rubin P.H., Friedman S., Harpaz N., Goldstein E., Weiser J., Schiller J., Waye J.D., Present D.H. Colonoscopic polypectomy in chronic colitis conservative management after endoscopic resection of dysplastic polyps. Gastroenterology. 117:1999;1295-1300
8. Engelsgjerd M., Farraye F.A., Odze R.D. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 117:1999;1288-1294
9. Ullman T., Croog V., Harpaz N., Sachar D., Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 125:2003;1311-1319
10. Ullman T.A., Loftus E.V., Kakar S., Burgart L.J., Sandborn W.J., Tremaine W.J. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol. 97:2002;922-927
11. Gorfine S.R., Bauer J., Harris M.T., Kreel I. Dysplasia complicating chronic ulcerative colitis is immediate colectomy warranted? Dis Colon Rectum. 43:2000;1575-1581
12. Tytgat G.N.J., Dhir V., Gopinath N. Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer. 31A:1995;1174-1177
13. Blackstone M.O., Riddell R.H., Rogers B.H.G., Levin B. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis an indication for colectomy. Gastroenterology. 80:1981;366-374
14. Butt J.H., Konishi F., Morson B.C., Lennard-Jones J.E., Ritchie J.K. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis. Dig Dis Sci. 28:1983;18-26
15. Bond J.H. Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice parameters committee of the American College of Gastroenterology. Am J Gastroenterol. 95:2000;3053-3063
16. Walsh S.V., Loda M., Torres C.M., Antonioli D., Odze R.D. p53 and β catenin expression in chronic ulcerative colitis-associated polypoid dysplasia and sporadic adenomas an immunohistochemical study. Am J Surg Pathol. 23:1999;963-969
17. Odze R., Brown C.A., Noffsinger A.E., Fogt F. Genetic alterations in chronic ulcerative colitis - associated adenoma-like DALMs are similar to non-colitic sporadic adenomas. Am J Surg Pathol. 24:2000;1209-1216
18. Selaru F.M., Xu Y., Yin J., Zou T., Liu T.C., Mori Y., Abraham J.M., Sato F., Wang S., Twigg C., Olaru A., Shustova V., Leytin A., Hytiroglou P., Shibata D., Harpaz N., Meltzer S.J. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesion. Gastroenterology. 122:2000;606-613
19. Fogt F., Vortmeyer A.O., Goldman H., Giordano T.J., Merino M.J., Zhuang Z. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma. Hum Pathol. 29:1998;131-136
20. Medlicott S.A.C., Jewell L.D., Price L., Fedorak R.N., Sherbaniuk R.W., Urbanski S.J. Conservative management of small adenomata in ulcerative colitis. Am J Gastroenterol. 92:1997;2094-2098
21. Nugent F.W., Haggitt R.C., Gilpin P.A. Cancer surveillance in ulcerative colitis. Gastroenterology. 100:1991;1241-1248
22. Marchesa P., Lashner B.A., Lavery I.C., Milsom J., Hull T.L., Strong S.A., Church J.M., Navarro G., Fazio V.W. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 92:1997;1285-1288
23. Shetty K., Rybicki L., Brezinski A., Carey W.D., Lashner B.A. The risk of cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 94:1999;1643-1649
24. Lennard-Jones J.E., Melville D.M., Morson B.C., Ritchie J.K., Williams C.B. Precancer and cancer in extensive ulcerative colitis findings among 401 patients over 22. Gut. 31:1990;800-806
25. Ekbom A., Helmick C., Zack M., Adami H. Ulcerative colitis and colorectal cancer a population-based study. N Engl J Med. 323:1990;1228-1233